National Brain Tumor Society

The National Comprehensive Cancer Network® (NCCN®) believes the best management of any patient with cancer is a clinical trial, but the idea of enrolling in a clinical trial may seem daunting. In this video, hear why Julio Piña, a patient with anaplastic ependymoma, and his wife Liz enrolled in a trial and what the process looked like. Learn more about clinical trials through NBTS’s MyTumorID campaign, and sign up to receive the latest news about clinical trials, biomarker testing, and more: https://lnkd.in/gKBnUW4u #ClinicalTrials #MyTumorID #NationalBrainTumorSociety

The holiday season can amplify the physical, emotional, and financial challenges that people living with brain tumors and their care partners already face. We invite you to share your story and tips with us to inform –– and possibly be featured in –– future NBTS content about navigating the holidays: https://lnkd.in/ePtxmXck

During his residency, Ranjit Bindra, MD, PhD, met a 3-year-old patient who tragically passed from a brainstem glioma. Her case drives much of the work he does today as a radiation oncologist treating patients with brain tumors at the Yale Cancer Center/Smilow Cancer Hospital and a researcher pursuing the latest breakthroughs. Dr. Bindra is co-director of NBTS’s DNA Damage Response Consortium, which has brought together a group of leading experts in both pediatric and adult neuro-oncology research across the U.S. to evaluate an emerging class of promising drugs that target the DNA damage response (DDR) networks in brain tumors. Thank you to Dr. Bindra and all brain tumor researchers for the important work they do every day to bring hope to the brain tumor community. #NationalBrainTumorSociety

Just 14 months after undergoing surgery and learning to walk again, Shawn W. crossed the finish line of a half marathon as a member of NBTS’s Gray Nation Endurance® team. And he didn’t stop there — expanding into advocacy, Shawn met with his representatives at NBTS’s 2024 Head to the Hill. There, his story of survivorship inspired Congressman John Joyce, MD, to become an original co-sponsor of the Bolstering Research And Innovation Now (BRAIN) Act, a landmark bipartisan bill designed to meet the unique needs of the #braintumor community. Your voice matters. Help us drive the urgently needed breakthroughs ahead by becoming an advocate or making a gift today at BrainTumor.org. #Head2Hill #NationalBrainTumorSociety

We know that returning to work after a #braintumor diagnosis can be challenging, from navigating any physical and cognitive changes to managing paperwork and logistics. What helped you reintegrate into your workplace? We invite you to share your story and tips with us to inform –– and possibly be featured in –– future NBTS content: https://lnkd.in/eKzjHP94

We're #NowHiring for a Associate Director, Gray Nation Endurance! To apply for this role, please send your cover letter and resume to careers@braintumor.org. For more information, please visit: https://lnkd.in/edvy9eFN Join a collaborative and relentlessly results-driven Development team as we carry out our mission of conquering and curing brain tumors — once and for all. The Associate Director of Gray Nation Endurance will report directly to the Director of Gray Nation Endurance to advance the strategic priorities of NBTS and execution for Gray Nation Endurance initiatives. This position will serve as lead staff on the National Brain Tumor Ride as the Signature Event of Gray Nation Endurance for NBTS, manage and host multiple endurance charity teams in established races, and will provide programmatic support as directed across the Gray Nation Endurance program. This position will work to ensure a positive volunteer and fundraiser experience through appropriate recruitment, recognition, retention and succession. The Associate Director of Gray Nation Endurance will oversee aspects of the Gray Nation Endurance®️ program (inclusive of select charity teams and the National Brain Tumor Ride), select charity partner race relationships, assigned projects, and volunteer management. #NationalBrainTumorSociety #GrayNationEndurance

The Brain Tumor Investment Fund (BTIF) is pleased to announce the first successful exit by a BTIF portfolio company, Modifi Bio. This acquisition demonstrates that investing in early-stage start-ups in the brain tumor space is critical to advancing promising treatments for patients with brain tumors and can provide a strong return on investment. We have long seen promise in Modifi’s approach to DNA damage response, and are pleased that our investment has helped them gain momentum. We congratulate Ranjit Bindra and the team at Modifi, and we are excited that Merck plans to take this treatment forward. Please see the full press release for more information: https://lnkd.in/gBZJw6w8 #BrainTumorInvestmentFund #BTIF

It was a privilege to join over 3,000+ New England #braintumor community members yesterday at the New England Brain Tumor Walk! Thank you to to all the inspiring teams and sponsors. A big shout of thanks to Erica (Steinig) Birke for representing the National Brain Tumor Society Board of Directors and Rachel Backner our lead staff and the entire amazing event committee of volunteers. We were so honored that our co-founder Bonnie Feldman attended and funded researchers including Nathalie Agar and innovative sponsors including Novocure, IQVIA, Mass General/Brigham Neurosurgery. Continue to join us and lend support at braintumor.org/newengland

Run the “Ragged Edge of the Western World” with NBTS! Applications are open to join our #GrayNationEndurance team for the 2025 Big Sur International Marathon, 11-Miler, or 12K. Spots will go fast - Apply today: https://lnkd.in/gxbQeviF #BSIM #NationalBrainTumorSociety

The #braintumor community of Greater Philadelphia came together on October 13th at the Race for Hope to raise awareness to support the needs of patients and their families. We were honored to sponsor and join in the race.    Thank you to our partner, the National Brain Tumor Society, for hosting this great event.    #braincancer #cancerresearch #glioblastoma